References
- MittalSEl-SeragHBEpidemiology of HCC: consider the populationJ Clin Gastroenterol201347S223632345
- HefaiedhREnnaiferRRomdhaneHGender difference in patients with hepatocellular carcinomaTunis Med20139150550824227507
- FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
- ParkinDMBrayFFerlayJJemalACancer in africa 2012Cancer Epidemiol Biomarkers Prev201423695396624700176
- ShariffMICoxIJGomaaAIKhanSAGedroycWTaylor-RobinsonSDHepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeuticsExpert Rev Gastroenterol Hepatol20093435336719673623
- El-SeragHBRudolphKLHepatocellular carcinoma: epidemiology and molecular carcinogenesisGastroenterology200713272557257617570226
- JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
- ChangM-HYouS-LChenC-JDecreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up studyJ Natl Cancer Inst2009101191348135519759364
- HolmesEWijeyesekeraATaylor-RobinsonSDNicholsonJKThe promise of metabolic phenotyping in gastroenterology and hepatologyNat Rev Gastroenterol Hepatol201512845847126194948
- BruixJShermanMManagement of hepatocellular carcinoma: an updateHepatology20115331020102221374666
- MazzaferroVLlovetJMMiceliRPredicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysisLancet Oncol2009101354319058754
- MacdonaldDCNelsonMBowerMPowlesTHepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART eraWorld J Gastroenterol20081411165718350596
- ChenC-JYangH-ISuJRisk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA levelJAMA20062951657316391218
- ChenJDYangHIIloejeUHCarriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related deathGastroenterology2010138517471754.e174120114048
- FornerALlovetJMBruixJHepatocellular carcinomaLancet201237998221245125522353262
- SingalAKSinghAJaganmohanSAntiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus–related cirrhosisClin Gastroenterol Hepatol20108219219919879972
- DonatoFTaggerAGelattiUAlcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and womenAm J Epidemiol2002155432333111836196
- HassanMMHwangLYHattenCJRisk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitusHepatology20023651206121312395331
- Schöniger-HekeleMMüllerCKutilekMOesterreicherCFerenciPGanglAHepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentationEur J Gastroenterol Hepatol200012894194810958223
- MarreroJAFontanaRJFuSConjeevaramHSSuGLLokASAlcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinomaJ Hepatol200542221822415664247
- MichelottiGAMachadoMVDiehlAMNAFLD, NASH and liver cancerNat Rev Gastroenterol Hepatol2013101165666524080776
- Neuschwander-TetriBACaldwellSHNonalcoholic steatohepatitis: summary of an AASLD Single Topic ConferenceHepatology20033751202121912717402
- El-SeragHBHampelHJavadiFThe association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidenceClin Gastroenterol Hepatol20064336938016527702
- El-seragHBTranTEverhartJEDiabetes increases the risk of chronic liver disease and hepatocellular carcinomaGastroenterology2004126246046814762783
- KewMCAflatoxins as a cause of hepatocellular carcinomaJ Gastrointestin Liver Dis201322330531024078988
- XiaQHuangX-YXueFGenetic polymorphisms of DNA repair genes and DNA repair capacity related to aflatoxin b1 (AFB1)-induced DNA damagesChenCNew Research Directions in DNA RepairInTech Publishers2013377412
- AguilarFHussainSPCeruttiPAflatoxin B1 induces the transversion of G--> T in codon 249 of the p53 tumor suppressor gene in human hepatocytesProc Natl Acad Sci U S A19939018858685908397412
- IARC Working Group on the Evaluation of Carcinogenesis Risks to HumansSome traditional herbal medicines, some mycotoxins, naphthalene and styreneIARC Monogr Eval Carcinog Risks Hum200282155612687954
- TillettTCarcinogenic crops: analyzing the effect of aflatoxin on global liver cancer ratesEnviron Health Perspect20101186A258
- FarinatiFMarinoDDe GiorgioMDiagnostic and prognostic role of α-fetoprotein in hepatocellular carcinoma: both or neither?Am J Gastroenterol2006101352453216542289
- GianniniEGMarencoSBorgonovoGAlpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosisHepatology20125641371137922535689
- NicholsonJKLindonJCHolmesE‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic dataXenobiotica199929111181118910598751
- EverettJRA new paradigm for known metabolite identification in metabonomics/metabolomics: metabolite identification efficiencyComput Struct Biotechnol J20151313114425750701
- FiehnOMetabolomics – the link between genotypes and phenotypesPlant Mol Biol2002481–215517111860207
- VillanuevaALlovetJMLiver cancer in 2013: mutational landscape of HCC – the end of the beginningNat Rev Clin Oncol2014112737424395088
- LocasaleJWCantleyLCAltered metabolism in cancerBMC Biol2010818820598111
- WarburgOÜber den stoffwechsel der carcinomzelle. [The metabolism of the carcinoma cell]Naturwissenschaften1924125011317 German
- LadepNGDonaACLewisMRDiscovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West AfricansHepatology20146041291130124923488
- EmwasA-HMThe strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics researchMethods Mol Biol2015127716119325677154
- HornakJPNMR Spectroscopy2017 Available from: https://www.cis.rit.edu/htbooks/nmr/chap-4/chap-4.htm#4.1Accessed March 10, 2017
- HolzgrabeUWawerIDiehlBNMR Spectroscopy in Pharmaceutical AnalysisAmsterdam, The NetherlandsElsevier2011
- StellaCBeckwith-HallBCloarecOSusceptibility of human metabolic phenotypes to dietary modulationJ Proteome Res20065102780278817022649
- Taylor-RobinsonSDSargentoniJBellJDIn vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liverLiver Int1997174198209
- LimAKPatelNHamiltonGHajnalJVGoldinRDTaylor-RobinsonSDThe relationship of in vivo31P MR spectroscopy to histology in chronic hepatitis CHepatology200337478879412668971
- KhanSACoxIJThillainayagamAVBansiDSThomasHCTaylor-RobinsonSDProton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancerEur J Gastroenterol Hepatol200517773373815947550
- AhmadMSymsRYoungICatheter-based flexible microcoil RF detectors for internal magnetic resonance imagingJ Micromech Microeng2009197074011
- EmwasA-HLuchinatCTuranoPStandardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a reviewMetabolomics201511487289426109927
- DonaACJiménezBSchäferHPrecision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotypingAnal Chem201486199887989425180432
- CoxIJAlievAECrosseyMMUrinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: a biomarker corroboration studyWorld J Gastroenterol20162216419127122669
- PosmaJMGarcia-PerezIDe IorioMSubset optimization by reference matching (STORM): an optimized statistical approach for recovery of metabolic biomarker structural information from 1H NMR spectra of biofluidsAnal Chem20128424106941070123151027
- WalshMCBrennanLMalthouseJPGRocheHMGibneyMJEffect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humansAm J Clin Nutr200684353153916960166
- LeverenceRAveryMJKavetskaiaOBiHHopCEGusevAISignal suppression/enhancement in HPLC-ESI-MS/MS from concomitant medicationsBiomed Chromatogr200721111143115017582231
- Romick-RosendaleLEGoodpasterAMHanwrightPJNMR-based metabonomics analysis of mouse urine and fecal extracts fol-lowing oral treatment with the broad-spectrum antibiotic enrofloxacin (Baytril)Magn Reson Chem200947S1S36S4619768747
- ShariffMILadepNGCoxIJCharacterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian populationJ Proteome Res2010921096110319968328
- CuledduNChessaMPorcuMCNMR-based metabolomic study of type 1 diabetesMetabolomics20128611621169
- SalekRMMaguireMLBentleyEA metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and humanPhysiol Genomics20072929910817190852
- EneaCSeguinFPetitpas-MulliezJ1H NMR-based metabolomics approach for exploring urinary metabolome modifications after acute and chronic physical exerciseAnal Bioanal Chem201039631167117619943160
- PechlivanisAKostidisSSaraslanidisP1H NMR-based metabonomic investigation of the effect of two different exercise sessions on the metabolic fingerprint of human urineJ Proteome Res20109126405641620932058
- SlupskyCMRankinKNWagnerJInvestigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profilesAnal Chem200779186995700417702530
- LenzEMBrightJWilsonIDMorganSNashAA 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjectsJ Pharm Biomed Anal20033351103111514656601
- ShamimWYousufuddinMBakhaiACoatsAJHonourJWGender differences in the urinary excretion rates of cortisol and androgen metabolitesAnn Clin Biochem200037677077411085621
- M-WYuC-JChenElevated serum testosterone levels and risk of hepatocellular carcinomaCancer Res19935347907948381328
- NauglerWESakuraiTKimSGender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 productionScience2007317583412112417615358
- ShariffMIGomaaAICoxIJUrinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation studyJ Proteome Res20111041828183621275434
- ChenJWangWLvSMetabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separationsAnal Chim Acta200965013919720165
- JengLBLoWYHsuWYAnalysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosisRapid Commun Mass Spectrom200923111543154919399767
- ShaoYZhuBZhengRDevelopment of urinary pseudotargeted LC-MS-based metabolomics method and its application in hepatocellular carcinoma biomarker discoveryJ Proteome Res201414290691625483141
- WuHXueRDongLMetabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometryAnal Chim Acta200964819810419616694
- ZhangASunHYanGHanYYeYWangXUrinary metabolic profiling identifies a key role for glycocholic acid in human liver cancer by ultra-performance liquid-chromatography coupled with high-definition mass spectrometryClin Chim Acta2013418869023313056
- KimhoferTFyeHTaylor-RobinsonSThurszMHolmesEProteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive reviewBr J Cancer20151127114125826224
- NicholsonJKHolmesEWilsonIDGut microorganisms, mammalian metabolism and personalized health careNat Rev Microbiol20053543143815821725
- RechnerARKuhnleGBremnerPHubbardGPMooreKPRice-EvansCAThe metabolic fate of dietary polyphenols in humansFree Radic Biol Med200233222023512106818
- SchachterDTaggartJVBenzoyl coenzyme A and hippurate synthesisJ Biol Chem1953203292593413084662
- HodgkinsonACitric acid excretion in normal adults and in patients with renal calculusClinical Sci19622320313963791
- ZuppiCMessanaIForniF1H NMR spectra of normal urines: reference ranges of the major metabolitesClin Chim Acta1997265185979352132
- ReboucheCJKinetics, pharmacokinetics, and regulation of l-carnitine and acetyl-l-carnitine metabolismAnn N Y Acad Sci200410331304115591001
- VazFMWandersRJCarnitine biosynthesis in mammalsBiochem J2002361341742911802770
- HotellingHThe most predictable criterionJ Educ Psychol1935262139
- BjerrumJTNielsenOHWangYLOlsenJTechnology insight: metabonomics in gastroenterology – basic principles and potential clinical applicationsNat Clin Pract Gastroenterol Hepatol20085633234318431374
- CloarecODumasM-ECraigAStatistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data setsAnal Chem20057751282128915732908
- BenjaminiYHochbergYControlling the false discovery rate: a practical and powerful approach to multiple testingJ R Stat Soc B (Methodological)199557289300
- BroadhurstDIKellDBStatistical strategies for avoiding false discoveries in metabolomics and related experimentsMetabolomics200624171196
- AueWKarhanJErnstRHomonuclear broad band decoupling and two-dimensional J-resolved NMR spectroscopyJ Chem Phys1976641042264227
- FrydmanLScherfTLupulescuAThe acquisition of multidimensional NMR spectra within a single scanProc Natl Acad Sci U S A20029925158581586212461169
- AueWBartholdiEErnstRRTwo-dimensional spectroscopy. Application to nuclear magnetic resonanceJ Chem Phys197664522292246
- BraunschweilerLErnstRCoherence transfer by isotropic mixing: application to proton correlation spectroscopyJ Magn Reson (1969)1983533521528
- ColomboMNatural history of hepatocellular carcinomaCancer Imaging200551858816154825